MaxLinear, Inc. (MXL) Financial Statements
MaxLinear, Inc. (MXL) reported trailing twelve-month revenue of $660.5M (up 56.0% year on year) and net income of -$29.4M as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$20.6M.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
MXLMaxLinear, Inc.Follow MXL — free
—
Price chart with a free account
- Market cap
- 5.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Jan, in 95 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.07 | 0.10 | 0.12 | 0.13 | 0.30 | 0.39 | 0.42 | 0.38 | 0.32 | 0.48 | 0.89 | 1.12 | 0.69 | 0.36 | 0.47 | 0.66 | |
| Gross profit | 0.05 | 0.06 | 0.07 | 0.08 | 0.16 | 0.23 | 0.21 | 0.21 | 0.17 | 0.21 | 0.50 | 0.65 | 0.39 | 0.19 | 0.27 | 0.38 | |
| Research & development | 0.04 | 0.05 | 0.05 | 0.06 | 0.09 | 0.10 | 0.11 | 0.12 | 0.10 | 0.18 | 0.28 | 0.30 | 0.27 | 0.23 | 0.21 | 0.22 | |
| Operating income | -0.02 | -0.01 | -0.01 | -0.01 | -0.04 | 0.06 | -0.02 | -0.02 | -0.02 | -0.10 | 0.07 | 0.18 | -0.04 | -0.22 | -0.13 | -0.01 | |
| Pre-tax income | -0.02 | -0.01 | -0.01 | -0.01 | -0.04 | 0.06 | -0.03 | -0.03 | -0.03 | -0.11 | 0.05 | 0.17 | -0.06 | -0.24 | -0.14 | -0.01 | |
| Income tax | 0.01 | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.02 | -0.01 | -0.01 | -0.02 | 0.01 | 0.05 | 0.01 | 0.01 | -0.00 | 0.01 | |
| Net income | -0.02 | -0.01 | -0.01 | -0.01 | -0.04 | 0.06 | -0.01 | -0.03 | -0.02 | -0.10 | 0.04 | 0.13 | -0.07 | -0.25 | -0.14 | -0.03 | |
| Diluted EPS ($) | -0.68 | -0.40 | -0.37 | -0.19 | -0.79 | 0.91 | -0.14 | -0.38 | -0.28 | -1.35 | 0.53 | 1.55 | -0.91 | -2.93 | -1.58 | -0.37 | |
| Diluted shares (bn) | 0.033 | 0.033 | 0.034 | 0.036 | 0.053 | 0.068 | 0.066 | 0.068 | 0.071 | 0.073 | 0.080 | 0.081 | 0.081 | 0.084 | 0.087 | — |
USD billions · SEC XBRL
MaxLinear, Inc. — questions
- What is MaxLinear, Inc.'s revenue?
- $660.5M over the twelve months to 2026-09-30, up 56.0% year on year, from its 10-Q and 10-K filings.
- What is MaxLinear, Inc.'s net income?
- -$29.4M over the twelve months to 2026-09-30.
- What is MaxLinear, Inc.'s free cash flow?
- -$20.6M over the twelve months to 2026-09-30.
- What are MaxLinear, Inc.'s diluted earnings per share?
- $-0.37 over the twelve months to 2026-09-30.
Every figure on this page comes from MaxLinear, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.